RT Book, Section
A1 Hunter, John G.
A1 Spight, Donn H.
A1 Sandone, Corinne
A1 Fairman, Jennifer E.
SR Print(0)
ID 1162530634
T1 Roux-En-Y Gastric Bypass
T2 Atlas of Minimally Invasive Surgical Operations
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071449052
LK accesssurgery.mhmedical.com/content.aspx?aid=1162530634
RD 2024/04/20
AB Laparoscopic  Roux-en-Y  gastric  bypass  (LRYGB)  is  indicated  for  patients  who  meet  the  1991  NIH  Consensus  criteria  for  bariatric  surgery.  These  indications  include  a  body  mass  index  (BMI)  of  40  kg/m2  or  greater  or  35  kg/m2  or  greater  and  the  presence  of  serious  obesity-related  comorbidities.  Additionally,  patients  must  have  failed  attempts  at  nonsurgical  weight  loss  such  as  supervised  medical  weight  loss  programs,  behavioral  therapy,  or  pharmacologic  therapy.  Comorbidities  that  are  frequently  associated  with  morbid  obesity  (and  improve  or  resolve  after  gastric  bypass)  include  obstructive  sleep  apnea,  obesity  hypoventilation  syndrome,  hypertension,  diabetes,  hyperlipidemia,  degenerative  joint  disease,  and  gastroesophageal  reflux  disease.  Other  obesity-related  comorbidities  include  venous  stasis  disease,  migraine  headaches,  pseudotumor  cerebri,  asthma,  infertility  or  menstrual  problems,  stress  urinary  incontinence,  gout,  and  skin  infections  related  to  a  pannus  or  skin  folds.